The financials
CRISPR Therapeutics AG by the numbers
Its largest product in Jun 2026 was Collaboration at $10M, 98% of the disclosed total, well ahead of Grant at 1.8%.
| Product | Revenue | Share |
|---|---|---|
| Collaboration | $10M | 98% |
| Grant | $181K | 1.8% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $10.2M (+598%)
Grant grew -80% year on year
Segment Latestquarter on quarteryear on year
- Collaboration$10.0M$10.0MQoQ +900%year on year -+900%-
- Grant$181.0K$181.0KQoQ -60%year on year -80%-60%-80%